Spark Therapeutics, Inc. (CIK: 0001609351) EDGAR, Information, Filings... CompaniesBIO.Com

Spark Therapeutics, Inc.

Mailing address
3737 MARKET STREET, SUITE 1300, PHILADELPHIA, Delaware, 19104
Phone
888-772-7560
State location
Pennsylvania
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Spark Therapeutics, Inc. (CIK: 0001609351) is an American company incorporated in the state of Pennsylvania. Head office is located at 3737 MARKET STREET, SUITE 1300, PHILADELPHIA, Pennsylvania, 19104. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Spark Therapeutics, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
ROCHE HOLDING LTD	0000889131	Dec-17-2019	10 percent owner
ROCHE HOLDINGS INC	0000904566	Dec-17-2019	10 percent owner
MILANO VINCENT	0001187159	Dec-17-2019	director
SIGAL ELLIOT	0001202294	Dec-17-2019	director
PEREZ ROBERT J	0001263230	Dec-17-2019	director
Zoth Lota S.	0001278219	Dec-17-2019	director, officer: CHIEF SCIENTIFIC OFFICER
Ekman Lars	0001376117	Dec-17-2019	director
Mehra Anand	0001590102	Dec-17-2019	director
Mingozzi Federico	0001732126	Dec-17-2019	officer: CHIEF SCIENTIFIC OFFICER
Dalton Lisa	0001732196	Dec-17-2019	officer: CHIEF HUMAN RESOURCE OFFICER
Faga Daniel	0001673528	Mar-25-2019	officer: Chief Business Officer
La Barge Joseph	0001673526	Mar-19-2019	officer: Chief Legal Officer
Furey John	0001691218	Dec-01-2016	officer: Chief Operating Officer
High Katherine A	0001631248	Oct-13-2015	director, officer: See Remarks
Webster Stephen W	0001438421	Oct-07-2015	officer: Chief Financial Officer
Altschuler Steven	0001458116	Oct-07-2015	director
Vivaldi Coelho Rogerio	0001610381	Oct-07-2015	officer: Chief Commercial Officer
Marrazzo Jeffrey D	0001631262	Oct-07-2015	director, officer: Chief Executive Officer
POWELL MICHAEL	0001202793	Jan-29-2015	10 percent owner
HEALY JAMES	0001245624	Jan-29-2015	10 percent owner
AKKARAJU SRINIVAS	0001253170	Jan-29-2015	10 percent owner
Sofinnova Venture Partners VIII, L.P.	0001524064	Jan-29-2015	10 percent owner
Sofinnova Management VIII, L.L.C.	0001559565	Jan-29-2015	10 percent owner
Betz Alert Lorris	0001631393	Jan-29-2015	director
Children's Hospital of Philadelphia Foundation	0001632060	Jan-29-2015	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Spark Therapeutics, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-20-021673 (34 Act) Size: KB	Feb-14-2020	005-88577 20619388
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0000950103-19-017784 (34 Act) Size: KB	Dec-27-2019	001-36819 191313279
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000950103-19-017350 ( Act) Size: 0 KB	Dec-18-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029453 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029452 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029449 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029447 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029446 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029444 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029440 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029438 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029435 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029434 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029433 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029428 ( Act) Size: 0 KB	Dec-17-2019
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029419 ( Act) Size: 0 KB	Dec-17-2019
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-19-316268 (33 Act) Size: KB	Dec-17-2019	333-201768 191290068
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000899243-19-029413 ( Act) Size: 0 KB	Dec-17-2019
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-19-316253 (33 Act) Size: KB	Dec-17-2019	333-210184 191289979
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-19-316252 (33 Act) Size: KB	Dec-17-2019	333-215578 191289971

Recent 20 filings. View all Spark Therapeutics, Inc. filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Spark Therapeutics, Inc. overview
Spark Therapeutics, Inc. job
Spark Therapeutics, Inc. stock
Spark Therapeutics, Inc. ownership
Spark Therapeutics, Inc. CEO
Spark Therapeutics, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.